Google vs. Death? Really?
By Pete Shanks,
Huffington Post
| 10. 03. 2013
Has Google gone right off the deep end? It's common for techies to be infatuated with transhumanism and other far-out ideas, but "solving death" seems like a real stretch. And yet that's what the megacompany's latest initiative is apparently meant to do.
Perhaps we should have seen this coming. The company did help start 23andMe, the direct-to-consumer genetic testing company run by co-founder Sergei Brin's (now estranged) wife. It also made a failed attempt to launch Google Health, a different data-storing effort. Even more significantly, it contributed to Singularity University, which isn't a university and doesn't have much to do with singularity but gets its name from the idea that "humans and machines will at some point merge, making old age and death meaningless." That's the kind of thinking that passes for radical in Silicon Valley.
Time magazine just published a cover story (mostly behind a pay wall) that is essentially a puff piece about Google. Most of the article focuses on Larry Page's tenure as CEO and the Google X division run by Brin. But the...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...